Immune-mediated attenuation of influenza illness after infection: opportunities and challenges
Open Access
- 24 September 2021
- journal article
- review article
- Published by Elsevier BV in The Lancet Microbe
- Vol. 2 (12), e715-e725
- https://doi.org/10.1016/s2666-5247(21)00180-4
Abstract
No abstract availableThis publication has 131 references indexed in Scilit:
- Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09Journal of Clinical Virology, 2013
- Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cellsProceedings of the National Academy of Sciences of the United States of America, 2012
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 virusesProceedings of the National Academy of Sciences of the United States of America, 2012
- Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human populationProceedings of the National Academy of Sciences of the United States of America, 2009
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusThe New England Journal of Medicine, 2009
- Aerosol transmission of influenza A virus: a review of new studiesJournal of The Royal Society Interface, 2009
- Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsNature, 2008
- The Pathology of Influenza Virus InfectionsAnnual review of pathology, 2008
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge StudiesAmerican Journal of Epidemiology, 2008
- A VIRUS OBTAINED FROM INFLUENZA PATIENTSThe Lancet, 1933